Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Actiq
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Actiq 200microgram loz with integral oromucosal applicator
0407020A0BCAAAI
|
Actiq | Fentanyl | Central Nervous System | 245 |
|
Actiq 400microgram loz with integral oromucosal applicator
0407020A0BCABAJ
|
Actiq | Fentanyl | Central Nervous System | 215 |
|
Actiq 600microgram loz with integral oromucosal applicator
0407020A0BCACAK
|
Actiq | Fentanyl | Central Nervous System | 29 |
|
Actiq 800microgram loz with integral oromucosal applicator
0407020A0BCADAL
|
Actiq | Fentanyl | Central Nervous System | 26 |
|
Actiq 1.6mg lozenges with integral oromucosal applicator
0407020A0BCAFAP
|
Actiq | Fentanyl | Central Nervous System | 13 |
|
Actiq 1.2mg lozenges with integral oromucosal applicator
0407020A0BCAEAN
|
Actiq | Fentanyl | Central Nervous System | 5 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.